Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network

The epidermal growth factor receptor (EGFR/ErbB1/Her1) belongs to the ErbB family of receptor tyrosine kinases (RTKs) and is a key player in the regulation of cell proliferation, differentiation, survival, and migration. Overexpression and mutational changes of EGFR have been identified in a variety of human cancers and the regulation of EGFR signaling plays a critical role in tumor development and progression. Due to its biological significance the EGFR signaling network is a widely used model system for the development of analytical techniques. Novel quantitative proteomics and phosphoproteomics approaches play an important role in the characterization of signaling pathways in a time and stimulus dependent manner. Recent studies discussed in this review provide new insights into different aspects of EGFR signal transduction, such as regulation and dynamics of its phosphorylation sites, association with interaction partners and identification of regulated phosphoproteins. Correlation of data from functional proteomics studies with results from other fields of signal transduction research by systems biology will be necessary to integrate and translate these findings into successful clinical applications.

[1]  P. De Camilli,et al.  Epidermal growth factor pathway substrate 15, Eps15. , 1999, The international journal of biochemistry & cell biology.

[2]  Roy S Herbst,et al.  Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.

[3]  Robert Hoffmann,et al.  HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms , 2005, BMC Bioinformatics.

[4]  D. Stern,et al.  Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[5]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[6]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[7]  J. Downward,et al.  Mechanism of Epidermal Growth Factor Regulation of Vav2, a Guanine Nucleotide Exchange Factor for Rac* , 2003, The Journal of Biological Chemistry.

[8]  G. Carpenter,et al.  Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor. , 1993, The Journal of biological chemistry.

[9]  H. Kitano,et al.  A comprehensive pathway map of epidermal growth factor receptor signaling , 2005, Molecular systems biology.

[10]  Monilola A. Olayioye,et al.  ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner , 1998, Molecular and Cellular Biology.

[11]  R. Singal,et al.  EGFR targeting of solid tumors. , 2007, Cancer control : journal of the Moffitt Cancer Center.

[12]  M. Mann,et al.  Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.

[13]  M. Kirschner,et al.  Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A Ciechanover,et al.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.

[15]  B. Druker,et al.  Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells , 2007, Proteomics.

[16]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[17]  B. Chait,et al.  Analysis of phosphorylated proteins and peptides by mass spectrometry. , 2001, Current opinion in chemical biology.

[18]  D. Lauffenburger,et al.  Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks , 2007, Proceedings of the National Academy of Sciences.

[19]  A. Tsygankov,et al.  The Cbl family proteins: Ring leaders in regulation of cell signaling , 2006, Journal of cellular physiology.

[20]  J Godovac-Zimmermann,et al.  Phosphotyrosine 1173 Mediates Binding of the Protein-tyrosine Phosphatase SHP-1 to the Epidermal Growth Factor Receptor and Attenuation of Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[21]  P. Sternberg,et al.  Positive and negative tissue-specific signaling by a nematode epidermal growth factor receptor. , 1997, Molecular biology of the cell.

[22]  D. Fenyo,et al.  Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells*S , 2005, Molecular & Cellular Proteomics.

[23]  Richard S. Johnson,et al.  Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor , 2003, Journal of the American Society for Mass Spectrometry.

[24]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[25]  Kristie L. Rose,et al.  Analysis of proteins and peptides on a chromatographic timescale by electron‐transfer dissociation MS , 2007, The FEBS journal.

[26]  M. Waterfield,et al.  Identification of a novel autophosphorylation site (P4) on the epidermal growth factor receptor. , 1989, The Biochemical journal.

[27]  Gavin MacBeath,et al.  A quantitative protein interaction network for the ErbB receptors using protein microarrays , 2006, Nature.

[28]  Monilola A. Olayioye,et al.  The ErbB receptor tyrosine family as signal integrators. , 2001, Endocrine-related cancer.

[29]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[30]  J. Cooper,et al.  Control of actin assembly and disassembly at filament ends. , 2000, Current opinion in cell biology.

[31]  D. Kassel,et al.  In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites. , 1995, Biochemistry.

[32]  E. Petricoin,et al.  Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S , 2006, Molecular & Cellular Proteomics.

[33]  Eoin Fahy,et al.  Identification of protein associations in organelles, using mass spectrometry-based proteomics. , 2004, Mass spectrometry reviews.

[34]  Lukas N. Mueller,et al.  SuperHirn – a novel tool for high resolution LC‐MS‐based peptide/protein profiling , 2007, Proteomics.

[35]  Etienne Gagnon,et al.  Organelle proteomics: looking at less to see more. , 2003, Trends in cell biology.

[36]  C. Huck,et al.  Quantitative detection of phosphoproteins by combination of two‐dimensional difference gel electrophoresis and phosphospecific fluorescent staining , 2005, Electrophoresis.

[37]  Joseph Schlessinger,et al.  A Novel Positive Feedback Loop Mediated by the Docking Protein Gab1 and Phosphatidylinositol 3-Kinase in Epidermal Growth Factor Receptor Signaling , 2000, Molecular and Cellular Biology.

[38]  Blagoy Blagoev,et al.  Quantitative proteomic assessment of very early cellular signaling events , 2007, Nature Biotechnology.

[39]  J. Yates,et al.  Proteomics of organelles and large cellular structures , 2005, Nature Reviews Molecular Cell Biology.

[40]  M. Fussenegger,et al.  Use of antibodies for detection of phosphorylated proteins separated by two‐dimensional gel electrophoresis , 2001, Proteomics.

[41]  Steven W. Taylor,et al.  Global organellar proteomics. , 2003, Trends in biotechnology.

[42]  E. Bradbury,et al.  Site-specific mass tagging with stable isotopes in proteins for accurate and efficient protein identification. , 2000, Analytical chemistry.

[43]  D. Lauffenburger,et al.  Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S , 2005, Molecular & Cellular Proteomics.

[44]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[45]  G. Tortora,et al.  Rational bases for the development of EGFR inhibitors for cancer treatment. , 2007, The international journal of biochemistry & cell biology.

[46]  D. Lauffenburger,et al.  Computational modeling of the EGF-receptor system: a paradigm for systems biology. , 2003, Trends in cell biology.

[47]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[48]  M. Matsuda,et al.  R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes. , 2007, Molecular biology of the cell.

[49]  A. Ullrich,et al.  All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. , 1989, The Journal of biological chemistry.

[50]  Albert Sickmann,et al.  State‐of‐the‐art in phosphoproteomics , 2005, Proteomics.

[51]  M. Mann,et al.  Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Gary D Bader,et al.  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.

[53]  Hanno Steen,et al.  Tyrosine Phosphorylation Mapping of the Epidermal Growth Factor Receptor Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[54]  Y. Kido,et al.  Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. , 1994, The Journal of biological chemistry.

[55]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[56]  W. Kolch,et al.  Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction. , 2006, Biochimica et biophysica acta.

[57]  Weidong Wu,et al.  Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor on Tyrosine 845 Is Required for Zinc-induced Ras Activation* , 2002, The Journal of Biological Chemistry.

[58]  M. Moran,et al.  Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation , 1997, Molecular and cellular biology.

[59]  Mark J. Bowser,et al.  EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[60]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[61]  W. Hong,et al.  Endofin, an Endosomal FYVE Domain Protein* , 2001, The Journal of Biological Chemistry.

[62]  A. Martin,et al.  Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines , 2007, Cell proliferation.

[63]  Jonathan M Irish,et al.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.

[64]  Tony Hunter,et al.  Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[65]  D. Arnott,et al.  Mass Spectrometric Contributions to the Practice of Phosphorylation Site Mapping through 2003 , 2005, Molecular & Cellular Proteomics.

[66]  J. Shabanowitz,et al.  A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. , 2004, Analytical chemistry.

[67]  T. Hunter,et al.  A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover , 1988, The Journal of cell biology.

[68]  O. Jensen Interpreting the protein language using proteomics , 2006, Nature Reviews Molecular Cell Biology.

[69]  Masao Nagasaki,et al.  Modeling and estimation of dynamic EGFR pathway by data assimilation approach using time series proteomic data. , 2006, Genome informatics. International Conference on Genome Informatics.

[70]  L. Huber,et al.  Subcellular fractionation, electromigration analysis and mapping of organelles. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[71]  L. Huber,et al.  Organelle proteomics: implications for subcellular fractionation in proteomics. , 2003, Circulation research.

[72]  N. Lydon,et al.  Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α (*) , 1995, The Journal of Biological Chemistry.

[73]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[74]  S. Skvortsov,et al.  Identification of Endosomal Epidermal Growth Factor Receptor Signaling Targets by Functional Organelle Proteomics *S , 2007, Molecular & Cellular Proteomics.

[75]  Lukas N. Mueller,et al.  An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. , 2008, Journal of proteome research.

[76]  M. Yaffe Phosphotyrosine-binding domains in signal transduction , 2002, Nature Reviews Molecular Cell Biology.

[77]  Joseph Schlessinger,et al.  SH2 and PTB Domains in Tyrosine Kinase Signaling , 2003, Science's STKE.

[78]  J. Borlak,et al.  Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics. , 2008, Mass spectrometry reviews.

[79]  A. Pandey,et al.  Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode. , 2001, Analytical chemistry.

[80]  Hanno Steen,et al.  Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. , 2002, Trends in biotechnology.

[81]  C. Ward,et al.  Systematic Mapping of Potential Binding Sites for Shc and Grb2 SH2 Domains on Insulin Receptor Substrate-1 and the Receptors for Insulin, Epidermal Growth Factor, Platelet-derived Growth Factor, and Fibroblast Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[82]  Giulio Superti-Furga,et al.  A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.

[83]  M. Mann,et al.  PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites , 2007, Genome Biology.

[84]  S. Parsons,et al.  STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor* , 2003, The Journal of Biological Chemistry.

[85]  William S Hancock,et al.  Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). , 2005, Journal of proteome research.

[86]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[87]  H. Cooper,et al.  Liquid Chromatography Electron Capture Dissociation Tandem Mass Spectrometry (LC-ECD-MS/MS) versus Liquid Chromatography Collision-induced Dissociation Tandem Mass Spectrometry (LC-CID-MS/MS) for the Identification of Proteins , 2007, Journal of the American Society for Mass Spectrometry.

[88]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[89]  R. Davis,et al.  Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. , 1989, The Journal of biological chemistry.

[90]  R. Epstein,et al.  Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells. , 2003, Molecular cancer therapeutics.

[91]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[92]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[93]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[94]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Tony Pawson,et al.  Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.

[96]  Karl Mechtler,et al.  Phosphoproteomics strategies for the functional analysis of signal transduction , 2006, Proteomics.

[97]  John Mendelsohn,et al.  The EGF receptor family as targets for cancer therapy , 2000, Oncogene.

[98]  David J Riese,et al.  Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[99]  Steven P Gygi,et al.  Signaling networks assembled by oncogenic EGFR and c-Met , 2008, Proceedings of the National Academy of Sciences.

[100]  M. Sliwkowski,et al.  Binding specificities and affinities of egf domains for ErbB receptors , 1999, FEBS letters.

[101]  Douglas A Lauffenburger,et al.  Modeling and computational analysis of EGF receptor-mediated cell communication in Drosophila oogenesis. , 2002, Development.

[102]  G. Carpenter,et al.  The Role of Individual SH2 Domains in Mediating Association of Phospholipase C-γ1 with the Activated EGF Receptor* , 1999, The Journal of Biological Chemistry.

[103]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[104]  T. Ito,et al.  Toward a protein-protein interaction map of the budding yeast: A comprehensive system to examine two-hybrid interactions in all possible combinations between the yeast proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[105]  J. Boonstra,et al.  Three classes of epidermal growth factor receptors on HeLa cells. , 1991, The Journal of biological chemistry.

[106]  Sampsa Hautaniemi,et al.  Effects of HER2 overexpression on cell signaling networks governing proliferation and migration , 2006, Molecular systems biology.

[107]  T. Kwok,et al.  Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors. , 1991, British Journal of Cancer.

[108]  M. Mann,et al.  Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics , 2004, Nature Biotechnology.

[109]  Y. Zhang,et al.  IntAct—open source resource for molecular interaction data , 2006, Nucleic Acids Res..

[110]  I. Dikic,et al.  Compartmentalization of growth factor receptor signalling. , 2005, Current opinion in cell biology.

[111]  Blagoy Blagoev,et al.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.

[112]  Albert Sickmann,et al.  Challenges in mass spectrometry‐based proteomics , 2004, Proteomics.

[113]  Y. Kido,et al.  Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. , 1998, Molecular endocrinology.

[114]  L. Alberghina,et al.  Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells , 1988, Molecular and cellular biology.

[115]  Tony Pawson,et al.  NetworKIN: a resource for exploring cellular phosphorylation networks , 2007, Nucleic Acids Res..

[116]  Brian A. Hemmings,et al.  Protein kinase B/Akt at a glance , 2005, Journal of Cell Science.

[117]  K. Helin,et al.  Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. , 1991, The Journal of biological chemistry.

[118]  W. Kolch Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[119]  H. Dohlman,et al.  MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. , 2005, Current opinion in chemical biology.

[120]  J. Downward,et al.  Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.

[121]  U. Hellman,et al.  Phosphoproteome profiling of transforming growth factor (TGF)-beta signaling: abrogation of TGFbeta1-dependent phosphorylation of transcription factor-II-I (TFII-I) enhances cooperation of TFII-I and Smad3 in transcription. , 2005, Molecular biology of the cell.

[122]  P. Bork,et al.  Proteome survey reveals modularity of the yeast cell machinery , 2006, Nature.

[123]  H. Steen,et al.  Quadrupole time-of-flight versus triple-quadrupole mass spectrometry for the determination of phosphopeptides by precursor ion scanning. , 2001, Journal of mass spectrometry : JMS.

[124]  A. Citri,et al.  EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.

[125]  Waltraud X. Schulze,et al.  A Novel Proteomic Screen for Peptide-Protein Interactions* , 2004, Journal of Biological Chemistry.

[126]  A. Ullrich,et al.  SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high‐affinity binding site for SH2 domains of phospholipase C gamma. , 1992, The EMBO journal.

[127]  F. White,et al.  Proteomic analysis of cellular signaling , 2004, Expert review of proteomics.

[128]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[129]  Kohjiro Ueki,et al.  Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone , 1997, Nature.

[130]  P. Bork,et al.  Functional organization of the yeast proteome by systematic analysis of protein complexes , 2002, Nature.

[131]  J. Furuhjelm,et al.  The C-terminal end of R-Ras contains a focal adhesion targeting signal , 2003, Journal of Cell Science.

[132]  Rebecca B. Riggins,et al.  Synergistic Promotion of c-Src Activation and Cell Migration by Cas and AND-34/BCAR3* , 2003, Journal of Biological Chemistry.

[133]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[134]  J. Bunkenborg,et al.  Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach. , 2007, Journal of proteome research.

[135]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[136]  M. Dreger Proteome analysis at the level of subcellular structures. , 2003, European journal of biochemistry.

[137]  T. Hunter,et al.  The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. , 1998, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[138]  T. Pawson,et al.  Assembly of Cell Regulatory Systems Through Protein Interaction Domains , 2003, Science.

[139]  C. Tacchetti,et al.  Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires c-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines* , 2002, The Journal of Biological Chemistry.

[140]  L. Silengo,et al.  Systematic Analysis of the Epidermal Growth Factor Receptor by Mass Spectrometry Reveals Stimulation-dependent Multisite Phosphorylation*S , 2005, Molecular & Cellular Proteomics.

[141]  Huang Shao,et al.  Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. , 2003, Cancer research.

[142]  G. M. Walton,et al.  Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. , 1990, The Journal of biological chemistry.

[143]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[144]  J. Schlessinger,et al.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[145]  S. Cole,et al.  Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions. , 2005, Journal of molecular biology.

[146]  L. Huber,et al.  Zooming in: Fractionation strategies in proteomics , 2004, Proteomics.

[147]  S. Snyder,et al.  Phospholipase C-γ: diverse roles in receptor-mediated calcium signaling , 2005 .

[148]  Y. Kido,et al.  Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells. , 1994, The Journal of biological chemistry.